About the Authors
- Ramin Radpour
-
Affiliation Laboratory for Gynecological Oncology, Department of Biomedicine/Women's Hospital, University of Basel, Basel, Switzerland
- Zeinab Barekati
-
Affiliation Laboratory for Gynecological Oncology, Department of Biomedicine/Women's Hospital, University of Basel, Basel, Switzerland
- Corina Kohler
-
Affiliation Laboratory for Gynecological Oncology, Department of Biomedicine/Women's Hospital, University of Basel, Basel, Switzerland
- Martin M. Schumacher
-
Affiliation Biomarker Development, Novartis Institutes of BioMedical Research, Novartis Pharma AG, Basel, Switzerland
- Thomas Grussenmeyer
-
Affiliation Department of Biomedicine and Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland
- Paul Jenoe
-
Affiliation Biozentrum, University of Basel, Basel, Switzerland
- Nicole Hartmann
-
Affiliation Biomarker Development, Novartis Institutes of BioMedical Research, Novartis Pharma AG, Basel, Switzerland
- Suzette Moes
-
Affiliation Biozentrum, University of Basel, Basel, Switzerland
- Martin Letzkus
-
Affiliation Biomarker Development, Novartis Institutes of BioMedical Research, Novartis Pharma AG, Basel, Switzerland
- Johannes Bitzer
-
Affiliation Department of Obstetrics and Gynecology, Women's Hospital, University of Basel, Basel, Switzerland
- Ivan Lefkovits
-
* E-mail: ivan.lefkovits@unibas.ch) (IL); frank.staedtler@novartis.com (FS); zhongx@uhbs.ch (XYZ)
Affiliation Department of Biomedicine and Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland
- Frank Staedtler
-
* E-mail: ivan.lefkovits@unibas.ch) (IL); frank.staedtler@novartis.com (FS); zhongx@uhbs.ch (XYZ)
Affiliation Biomarker Development, Novartis Institutes of BioMedical Research, Novartis Pharma AG, Basel, Switzerland
- Xiao Yan Zhong
-
* E-mail: ivan.lefkovits@unibas.ch) (IL); frank.staedtler@novartis.com (FS); zhongx@uhbs.ch (XYZ)
Affiliation Laboratory for Gynecological Oncology, Department of Biomedicine/Women's Hospital, University of Basel, Basel, Switzerland
Competing Interests
MS, NH, ML and FS are employees of Novartis Pharma AG, Basel, Switzerland. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RR IL FS XYZ. Performed the experiments: RR ZB CK TG PJ NH SM ML. Analyzed the data: RR ZB MS TG IL. Contributed reagents/materials/analysis tools: JB FS. Wrote the paper: RR ZB IL FS.